课题基金 / 基金详情

A high-throughput single-cell technology for the function-based discovery of monoclonal antibody antagonists of G-protein coupled receptors in cancer

A high-throughput single-cell technology for the function-based discovery of monoclonal antibody antagonists of G-protein coupled receptors in cancer
用于基于功能发现癌症中 G 蛋白偶联受体单克隆抗体拮抗剂的高通量单细胞技术
批准号:
307343
负责人:
Hansen Carl L
金额:
$89.81万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2014
资助国家:
加拿大
项目状态:
已结题
起止时间:
2014-03-01 至 2019-03-01

项目摘要

项目成果

Hansen Carl L的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Antibodies are proteins that are naturally made by the body to fight infections and disease. The immune system is capable of making an immense diversity of different antibodies, each able to recognize and eliminate a specific target (e.g. a virus, bacteri
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Microfluidic technology platform for selection of functional monoclonal antibodies with application to fibrosis
  • 批准号:
    316153
  • 项目类别:
    Operating Grants
  • 资助金额:
    $32.24万
  • 财政年份:
    2014
  • 负责人:
    Hansen Carl L
  • 依托单位:
Pre-commercial development of single cell antibody selection process
  • 批准号:
    256777
  • 项目类别:
    Operating Grants
  • 资助金额:
    $11.23万
  • 财政年份:
    2012
  • 负责人:
    Hansen Carl L
  • 依托单位:
The development of single cell microfluidic technologies for analysis of microRNA expression and epigenetic state with application to hematopoietic stem cells
  • 批准号:
    248047
  • 项目类别:
    Operating Grants
  • 资助金额:
    $55.25万
  • 财政年份:
    2011
  • 负责人:
    Hansen Carl L
  • 依托单位:
Deciphering signalling complexity at the single cell level using high-throughput microfluidic imaging.
  • 批准号:
    191823
  • 项目类别:
    Operating Grants
  • 资助金额:
    $0.07万
  • 财政年份:
    2009
  • 负责人:
    Hansen Carl L
  • 依托单位:
海外基金